TOMM20L divergent transcript (TOMM20L-DT)

TOMM20L divergent transcript (TOMM20L-DT) is a long non-coding RNA (lncRNA) gene locus located near the TOMM20L gene on chromosome 14 in Homo sapiens[1][6]. Unlike TOMM20L, which is a protein-coding gene involved in mitochondrial protein import, TOMM20L-DT does not encode a protein and has no established function, role as a drug target, interaction with known drugs, or biomarker status. There is currently insufficient information regarding its biological function, disease relevance, or potential as a therapeutic target[1][6]. Context and Rationale: - The "divergent transcript" (DT) nomenclature refers to a lncRNA arising from the TOMM20L gene locus but in a divergent or antisense orientation, indicating non-coding potential and a lack of protein product[1][6]. - Existing databases (GeneCards, NCBI Gene, BioGPS) provide no evidence that TOMM20L-DT is a protein, receptor, transporter, or otherwise a canonical therapeutic target[1][4][6][7]. - All available resources describe TOMM20L-DT as an RNA gene, not as a functional protein or target for drugs[1][6]. - The protein-coding gene TOMM20L (Translocase of outer mitochondrial membrane 20 like) is sometimes referenced, but TOMM20L-DT is distinct and unrelated to TOMM20 (which is a mitochondrial protein import receptor)[1][7]. Misattribution of TOMM20L-DT as a functional receptor or target would be incorrect. Key judgement: TOMM20L divergent transcript (TOMM20L-DT) is not a therapeutic target, is often mistaken for the protein-coding TOMM20L or TOMM20 genes, and should not be used in target nomenclature when referring to a therapeutic protein or receptor[1][6][7].

Other names

TOMM20L-DTTOMM20L divergent transcript